Martell Bridget A
SEC insider (Form 3/4/5 filer). CIK 0001629627. Director at Aligos Therapeutics, Inc. (ALGS) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Martell Bridget A has filed insider reports for
- Aligos Therapeutics, Inc. (ALGS): Director
- DELCATH SYSTEMS, INC. (DCTH): Director
- ACHIEVE LIFE SCIENCES, INC. (ACHV): Director
Martell Bridget A
CIK: 0001629627
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.9K shares- - May 13, 2026DCTH
DELCATH SYSTEMS, INC.
AwardDirectStock Option (right to buy)
22.5K shares- - Jun 25, 2025ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.9K shares- - Jun 6, 2025ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectStock Option (right to buy)
31.5K shares- - May 15, 2025DCTH
DELCATH SYSTEMS, INC.
AwardDirectStock Option (right to buy)
22.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| May 13, 2026 |  DCTH DELCATH SYSTEMS, INC. | Award Stock Option (right to buy) | 22,500 | - | - | Direct |
| Jun 25, 2025 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| Jun 6, 2025 |  ACHV ACHIEVE LIFE SCIENCES, INC. | Award Stock Option (right to buy) | 31,500 | - | - | Direct |
| May 15, 2025 | DCTH DELCATH SYSTEMS, INC. | Award Stock Option (right to buy) | 22,500 | - | - | Direct |
1-5 of 5 transactions